Liminatus Pharma, Inc.

Biotechnology • Healthcare • La Palma, CA, United States • LIMNW (NCM)

Liminatus Pharma, Inc. operates as a pre-clinical stage biopharmaceutical company that develops novel cancer therapies. It is developing CD47, a high affinity humanized anti CD47 antibody that has the potential to translate into clinic for CD47 SIRPa blocking and restoring the anti-tumor function of innate immune cells without inducing hemagglutination or hemolysis. The company was founded in 2018 is based in LA Palma, California.

213 273 5453 6 Centerpointe Drive, La Palma, CA 90623, United States

Stock Performance (90 Days)

Data through Dec 26, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Liminatus Pharma (NASDAQ: LIMN) signs MOU for $30M earn-out with Capital Trust Group - Stock Titan

Stock Titan • Oct 30

Liminatus Pharma stock soars after engaging Digital Offering for capital raise - Investing.com

Investing.com • Jul 24

Liminatus Pharma Rings the Closing Bell - Nasdaq

Nasdaq • Aug 7

Liminatus Pharma Stock Surges to Record High After Regaining Nasdaq Compliance - Stocktwits

Stocktwits • Jun 5

Liminatus Pharma: CD47 Hasn't Worked For Anyone, But Is This The Exception? - Seeking Alpha

Seeking Alpha • Jun 24

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Liminatus Pharma, Inc. had layoffs?

No layoff events have been recorded for Liminatus Pharma, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

What industry is Liminatus Pharma, Inc. in?

Liminatus Pharma, Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is Liminatus Pharma, Inc. a publicly traded company?

Yes, Liminatus Pharma, Inc. is publicly traded under the ticker symbol LIMNW on the NCM.

Where is Liminatus Pharma, Inc. headquartered?

Liminatus Pharma, Inc. is headquartered in La Palma, CA, United States at 6 Centerpointe Drive, La Palma, CA 90623, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.